|
|
Volumn 189, Issue 4, 2007, Pages
|
|
Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?".
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSTIC AGENT;
GADODIAMIDE;
GADOLINIUM PENTETATE;
ADULT;
COMORBIDITY;
EPIDEMIOLOGY;
FEMALE;
FIBROSIS;
HUMAN;
INCIDENCE;
KIDNEY FAILURE;
MALE;
METHODOLOGY;
MIDDLE AGED;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RENAL REPLACEMENT THERAPY;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SKIN DISEASE;
STATISTICS;
UNITED STATES;
ADULT;
CALIFORNIA;
CAUSALITY;
COMORBIDITY;
FEMALE;
FIBROSIS;
GADOLINIUM DTPA;
HUMANS;
INCIDENCE;
KIDNEY FAILURE;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
SKIN DISEASES;
|
|
EID: 35348910761
PISSN: None
EISSN: 15463141
Source Type: Journal
DOI: 10.2214/AJR.07.2919 Document Type: Note |
|
Times cited : (23)
|
|
References (0)
|
